{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:54:28Z","timestamp":1768683268451,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T00:00:00Z","timestamp":1438473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40272-015-0143-3","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T10:51:29Z","timestamp":1438426289000},"page":"361-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder"],"prefix":"10.1007","volume":"17","author":[{"given":"Daniel F.","family":"Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,2]]},"reference":[{"key":"143_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","edition":"5"},{"key":"143_CR2","volume-title":"International classification of diseases and related health problems","author":"World Health Organization","year":"1992","unstructured":"World Health Organization. International classification of diseases and related health problems. Geneva, Switzerland: WHO; 1992."},{"issue":"12","key":"143_CR3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","volume":"56","author":"Multimodal Treatment of ADHD Group","year":"1999","unstructured":"Multimodal Treatment of ADHD Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073\u201386.","journal-title":"Arch Gen Psychiatry"},{"key":"143_CR4","first-page":"140","volume-title":"Attention-deficit hyperactivity disorder: a handbook for diagnosis & treatment","author":"SR Pliszka","year":"2015","unstructured":"Pliszka SR. Comorbid psychiatric disorder in children with ADHD. In: Barkley RA, editor. Attention-deficit hyperactivity disorder: a handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. p. 140\u201368.","edition":"4"},{"issue":"1","key":"143_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1087054708319345","volume":"12","author":"J Swanson","year":"2008","unstructured":"Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008;12(1):4\u201314.","journal-title":"J Atten Disord"},{"key":"143_CR6","volume-title":"ADHD in adults. What the science says","author":"RA Barkley","year":"2008","unstructured":"Barkley RA, Murphy KR, Fischer M. ADHD in adults. What the science says. New York: Guilford Press; 2008."},{"issue":"2","key":"143_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/1087054707308486","volume":"12","author":"DF Connor","year":"2008","unstructured":"Connor DF, Doerfler LA. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders? J Atten Disord. 2008;12(2):126\u201334.","journal-title":"J Atten Disord"},{"issue":"5","key":"143_CR8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/DBP.0b013e3181e121bd","volume":"31","author":"DF Connor","year":"2010","unstructured":"Connor DF, Steeber J, McBurnett K. A review of attention-deficit\/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010;31(5):427\u201340.","journal-title":"J Dev Behav Pediatr"},{"issue":"2","key":"143_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.chi.0000189134.97436.e2","volume":"45","author":"RA Barkley","year":"2006","unstructured":"Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192\u2013202.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"143_CR10","first-page":"327","volume":"17","author":"TP Beauchaine","year":"2010","unstructured":"Beauchaine TP, Hinshaw SP, Pang KL. Comrobidity of attention-deficit\/hyperactivity disorder and early-onset conduct disorder: Biological, environmental, and developmental mechanisms. Clin Psychol: Sci Pract. 2010;17:327\u201336.","journal-title":"Clin Psychol: Sci Pract"},{"key":"143_CR11","first-page":"411","volume-title":"Child and adolescent psychopathology","author":"ID Waldman","year":"2013","unstructured":"Waldman ID, Lahey BB. Oppositional defiant disorder, conduct disorder, and juvenile delinquency. In: Beauchaine TP, Hinshaw SP, editors. Child and adolescent psychopathology. 2nd ed. Hoboken, New Jersey: Wiley; 2013. p. 411\u201352.","edition":"2"},{"issue":"9","key":"143_CR12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00004583-199609000-00019","volume":"35","author":"E Taylor","year":"1996","unstructured":"Taylor E, Chadwick O, Heptinstall E, et al. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1213\u201326.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"143_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10578-009-0171-8","volume":"41","author":"SS Pauw De","year":"2010","unstructured":"De Pauw SS, Mervielde I. Temperament, personality and developmental psychopathology: a review based on the conceptual dimensions underlying childhood traits. Child Psychiatry Hum Dev. 2010;41(3):313\u201329.","journal-title":"Child Psychiatry Hum Dev"},{"key":"143_CR14","first-page":"453","volume-title":"Child and adolescent psychopathology","author":"TJ Dishion","year":"2013","unstructured":"Dishion TJ, Racer KH. Development of adult antisocial behavior. In: Beauchaine TP, Hinshaw SP, editors. Child and adolescent psychopathology. 2nd ed. Hoboken, New Jersey: Wiley; 2013. p. 453\u201387.","edition":"2"},{"issue":"1","key":"143_CR15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.chi.0000246060.62706.af","volume":"46","author":"H Steiner","year":"2007","unstructured":"Steiner H, Remsing L. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):126\u201341.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"143_CR16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1469-7610.00484","volume":"40","author":"BB Lahey","year":"1999","unstructured":"Lahey BB, Waldman ID, McBurnett K. Annotation: the development of antisocial behavior: an integrative causal model. J Child Psychol Psychiatry. 1999;40(5):669\u201382.","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"143_CR17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10802-005-6737-4","volume":"33","author":"LJ Pfiffner","year":"2005","unstructured":"Pfiffner LJ, McBurnett K, Rathouz PJ, et al. Family correlates of oppositional and conduct disorders in children with attention deficit\/hyperactivity disorder. J Abnorm Child Psychol. 2005;33(5):551\u201363.","journal-title":"J Abnorm Child Psychol"},{"issue":"1","key":"143_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00004703-200102000-00008","volume":"22","author":"PS Jensen","year":"2001","unstructured":"Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60\u201373.","journal-title":"J Dev Behav Pediatr"},{"issue":"11","key":"143_CR19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1469-7610.2005.00422.x","volume":"46","author":"JD Burke","year":"2005","unstructured":"Burke JD, Loeber R, Lahey BB, et al. Developmental transitions among affective and behavioral disorders in adolescent boys. J Child Psychol Psychiatry. 2005;46(11):1200\u201310.","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"143_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1009567419190","volume":"3","author":"R Loeber","year":"2000","unstructured":"Loeber R, Green SM, Lahey BB, et al. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000;3(1):37\u201360.","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"10","key":"143_CR21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/ern.12.119","volume":"12","author":"MT Villodas","year":"2012","unstructured":"Villodas MT, Pfiffner LJ, McBurnett K. Prevention of serious conduct problems in youth with attention deficit\/hyperactivity disorder. Expert Rev Neurother. 2012;12(10):1253\u201363.","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"143_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/chi.0b013e318033ff59","volume":"46","author":"JH Satterfield","year":"2007","unstructured":"Satterfield JH, Faller KJ, Crinella FM, et al. A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry. 2007;46(5):601\u201310.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"143_CR23","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1097\/00004583-199710001-00007","volume":"36","author":"American Academy of Child and Adolescent Psychiatry","year":"1997","unstructured":"American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36:85S\u2013121S.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10 Suppl","key":"143_CR24","first-page":"1386","volume":"31","author":"American Academy of Child and Adolescent Psychiatry","year":"1997","unstructured":"American Academy of Child and Adolescent Psychiatry. Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;31(10 Suppl):1386\u2013402.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"143_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/pir.21-8-265","volume":"21","author":"TM Achenbach","year":"2000","unstructured":"Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral\/emotional problems and competencies. Pediatr Rev. 2000;21(8):265\u201371.","journal-title":"Pediatr Rev"},{"key":"143_CR26","volume-title":"Conners Rating Scales-Revised","author":"CK Conners","year":"2008","unstructured":"Conners CK. Conners Rating Scales-Revised, 3rd edn. North Tonawanda, NY: Multi-Health Systems; 2008.","edition":"3"},{"key":"143_CR27","volume-title":"Behavioral assessment system for children","author":"C Reynolds","year":"2004","unstructured":"Reynolds C, Kamphaus R. Behavioral assessment system for children. Circle Pines, MN: American Guidance Service; 2004."},{"key":"143_CR28","unstructured":"Swanson JM. The SNAP-IV Teacher and Parent Rating Scale. http:\/\/www.adhd.net\/snap-iv-form.pdf . Accessed 25 Nov 2014."},{"key":"143_CR29","unstructured":"Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS). http:\/\/imaging.cmpmedica.com\/CME\/pt\/PDF\/VADPRS_Quest.pdf . Accessed 25 Nov 2014."},{"key":"143_CR30","volume-title":"Attention-deficit hyperactivity disorder. A handbook for diagnosis & treatment","author":"RA Barkley","year":"2015","unstructured":"Barkley RA. Attention-deficit hyperactivity disorder. A handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015.","edition":"4"},{"issue":"11","key":"143_CR31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.biopsych.2004.09.008","volume":"57","author":"EJ Sonuga-Barke","year":"2005","unstructured":"Sonuga-Barke EJ. Causal models of attention-deficit\/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005;57(11):1231\u20138.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"143_CR32","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.biopsych.2004.08.025","volume":"57","author":"JT Nigg","year":"2005","unstructured":"Nigg JT, Willcutt EG, Doyle AE, et al. Causal heterogeneity in attention-deficit\/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224\u201330.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"143_CR33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chc.2014.05.014","volume":"23","author":"LJ Pfiffner","year":"2014","unstructured":"Pfiffner LJ, Haack LM. Behavior management for school-aged children with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):731\u201346.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"143_CR34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3928\/00904481-20080101-03","volume":"37","author":"SW Evans","year":"2008","unstructured":"Evans SW, Schultz BK, Sadler JM. Safety and efficacy of psychosocial interventions used to treat children with attention-deficit\/hyperactivity disorder. Pediatr Ann. 2008;37(1):52\u20139.","journal-title":"Pediatr Ann"},{"issue":"1","key":"143_CR35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaac.2012.10.001","volume":"52","author":"JS Comer","year":"2013","unstructured":"Comer JS, Chow C, Chan PT, et al. Psychosocial treatment efficacy for disruptive behavior problems in very young children: a meta-analytic examination. J Am Acad Child Adolesc Psychiatry. 2013;52(1):26\u201336.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"143_CR36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.chc.2014.06.003","volume":"23","author":"SV Faraone","year":"2014","unstructured":"Faraone SV, Antshel KM. Towards an evidence-based taxonomy of nonpharmacologic treatments for ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):965\u201372.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"3","key":"143_CR37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.clinthera.2006.03.006","volume":"28","author":"TJ Spencer","year":"2006","unstructured":"Spencer TJ, Abikoff HB, Connor DF, et al. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit\/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther. 2006;28(3):402\u201318.","journal-title":"Clin Ther"},{"issue":"9","key":"143_CR38","first-page":"755","volume":"24","author":"DF Connor","year":"2010","unstructured":"Connor DF, Findling RL, Kollins SH, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6\u201312 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24(9):755\u201368.","journal-title":"CNS Drugs"},{"issue":"8","key":"143_CR39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00004583-200108000-00014","volume":"40","author":"D Thiruchelvam","year":"2001","unstructured":"Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"143_CR40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.56.12.1088","volume":"56","author":"Multimodal Treatment of ADHD Group","year":"1999","unstructured":"Multimodal Treatment of ADHD Group. Moderators and mediators of treatment response for children with attention-deficit\/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1088\u201396.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"143_CR41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.113.4.754","volume":"113","author":"Multimodal Treatment of ADHD Group","year":"2004","unstructured":"Multimodal Treatment of ADHD Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit\/hyperactivity disorder. Pediatrics. 2004;113(4):754\u201361.","journal-title":"Pediatrics"},{"issue":"4","key":"143_CR42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","volume":"19","author":"SV Faraone","year":"2010","unstructured":"Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353\u201364.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"143_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00213-007-0840-x","volume":"194","author":"JYW Cheng","year":"2007","unstructured":"Cheng JYW, Chen RYL, Ko JSN, et al. Efficacy and safety of atomoxetine for attention-deficit\/hyperactivity disorder in children and adolescents-meta-analysis and meta-review. Psychopharmacology. 2007;194:197\u2013209.","journal-title":"Psychopharmacology"},{"issue":"5","key":"143_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D Michelson","year":"2001","unstructured":"Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled. Dose Response Study. Pediatrics. 2001;108(5):1\u20139.","journal-title":"Pediatrics"},{"issue":"1","key":"143_CR45","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","volume":"121","author":"J Biederman","year":"2008","unstructured":"Biederman J, Melmed RD, Patel A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder. Pediatrics. 2008;121(1):e73\u201384.","journal-title":"Pediatrics"},{"issue":"5","key":"143_CR46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/cap.2013.0028","volume":"23","author":"F Sallee","year":"2013","unstructured":"Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of alpha2-adrenoceptor agonists for the treatment of attention-deficit\/hyperactivity and related disorders. J Child Adolesc Psychopharmacol. 2013;23(5):308\u201319.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"143_CR47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CHI.0b013e318191769e","volume":"48","author":"FR Sallee","year":"2009","unstructured":"Sallee FR, McGough J, Wigal T, et al. Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48(2):155\u201365.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"143_CR48","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2010-0086","volume":"126","author":"JC Blader","year":"2010","unstructured":"Blader JC, Pliszka SR, Jensen PS, et al. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics. 2010;126(4):e796\u2013806.","journal-title":"Pediatrics"},{"issue":"6","key":"143_CR49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00004583-199706000-00011","volume":"36","author":"RJ Schachar","year":"1997","unstructured":"Schachar RJ, Tannock R, Cunningham CE, et al. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry. 1997;36(6):754\u201363.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"143_CR50","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1542\/peds.2006-1880","volume":"121","author":"ME Bangs","year":"2008","unstructured":"Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008;121(2):e314\u201320.","journal-title":"Pediatrics."},{"issue":"3","key":"143_CR51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004583-200503000-00008","volume":"44","author":"JH Newcorn","year":"2005","unstructured":"Newcorn JH, Spencer TJ, Biederman J, et al. Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):240\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"143_CR52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/chi.0b013e31815d9af7","volume":"47","author":"DR Palumbo","year":"2008","unstructured":"Palumbo DR, Sallee FR, Pelham WE Jr, et al. Clonidine for attention-deficit\/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(2):180\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"143_CR53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/cap.2013.0103","volume":"24","author":"RL Findling","year":"2014","unstructured":"Findling RL, McBurnett K, White C, et al. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014;24(5):245\u201352.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"143_CR54","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0883073808315412","volume":"23","author":"KD Gadow","year":"2008","unstructured":"Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol. 2008;23(9):981\u201390.","journal-title":"J Child Neurol"},{"issue":"1","key":"143_CR55","first-page":"47 e1","volume":"53","author":"MG Aman","year":"2014","unstructured":"Aman MG, Bukstein OG, Gadow KD, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry. 2014;53(1):47 e1\u201360 e1.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"143_CR56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.chc.2014.05.003","volume":"23","author":"GJ DuPaul","year":"2014","unstructured":"DuPaul GJ, Gormley MJ, Laracy SD. School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):687\u201397.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"143_CR57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chc.2014.06.001","volume":"23","author":"AL Robin","year":"2014","unstructured":"Robin AL. Family therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):747\u201356.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"143_CR58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chc.2014.05.007","volume":"23","author":"AY Mikami","year":"2014","unstructured":"Mikami AY, Jia M, Na JJ. Social skills training. Child Adolesc Psychiatr Clin N Am. 2014;23(4):775\u201388.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"143_CR59","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.chc.2014.05.001","volume":"23","author":"KM Antshel","year":"2014","unstructured":"Antshel KM, Olszewski AK. Cognitive behavioral therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):825\u201342.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"143_CR60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chc.2014.08.002","volume":"24","author":"KM Antshel","year":"2015","unstructured":"Antshel KM. Psychosocial interventions in attention-deficit\/hyperactivity disorder: update. Child Adolesc Psychiatr Clin N Am. 2015;24(1):79\u201397.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"143_CR61","first-page":"666","volume-title":"Attention-Deficit hyperactivity disorder: a handbook for diagnosis & treatment","author":"DF Connor","year":"2015","unstructured":"Connor DF. Stimulant and nonstimulant medications for childhood ADHD. In: Barkley RA, editor. Attention-Deficit hyperactivity disorder: a handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. p. 666\u201385.","edition":"4"},{"issue":"4","key":"143_CR62","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","volume":"108","author":"American Academy of Pediatrics","year":"2001","unstructured":"American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyperactivity disorder. Pediatrics. 2001;108(4):1033\u201344.","journal-title":"Pediatrics"},{"issue":"3","key":"143_CR63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004583-200203000-00004","volume":"41","author":"DF Connor","year":"2002","unstructured":"Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt\/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41(3):253\u201361.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"143_CR64","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","volume":"46","author":"S Pliszka","year":"2007","unstructured":"Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894\u2013921.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 1","key":"143_CR65","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1177\/070674370200601S11","volume":"6","author":"L Greenhill","year":"2002","unstructured":"Greenhill L, Beyer DH, Finkleson J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit\/ hyperactivity disorder. J Atten Disord. 2002;6(Suppl 1):S89\u2013100.","journal-title":"J Atten Disord"},{"issue":"2","key":"143_CR66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaac.2010.11.005","volume":"50","author":"R Jain","year":"2011","unstructured":"Jain R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(2):171\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"143_CR67","doi-asserted-by":"crossref","first-page":"948 e1","DOI":"10.1016\/j.jaac.2014.05.008","volume":"53","author":"KD Gadow","year":"2014","unstructured":"Gadow KD, Arnold LE, Molina BS, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry. 2014;53(9):948 e1\u2013959 e1.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"143_CR68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2011.0015","volume":"21","author":"L Maayan","year":"2011","unstructured":"Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21(6):517\u201335.","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-015-0143-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0143-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:13:49Z","timestamp":1567037629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-015-0143-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,2]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1007\/s40272-015-0143-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,2]]}}}